AUGUST 2022LIFE SCIENCES REVIEW4CONTENTSCONTENTSAdvanced Therapies for Patients Suffering from PAHLAST WORD30Analytics as a competitive advantage takes 3 things ­ access, cleanliness, and actionMatt Southwick, Executive Director, Clinical Systems and Analytical Reporting, AmgenIN MY OPINION08Shola Oyewole, CIO, United Therapeutics Corporation [NASDAQ:UTHR]12SETTING A NEW STANDARD IN PATIENT RECRUITMENT AND RETENTION FOR CLINICAL TRIALSVICTORIA DONOVAN,CEO AND FOUNDER
< Page 3 | Page 5 >